V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240012611 | 240015452 | null | 82 | Curative (C) | 2015-01-01 | 2015-01-02 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | null | 240018745 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 240012612 | 240015452 | null | 81.7 | Curative (C) | 2013-05-16 | 2013-06-07 | Triple / Double Intrathecal Therapy | N | null | 240018745 | BORTEZOMIB + RITUXIMAB |
| 240012613 | 240008814 | 0 | 91 | Palliative (P) | 2013-04-19 | 2013-10-22 | Irinotecan + Modified De Gramont | Y | N | 240018953 | VINORELBINE |
| 240012614 | 240008815 | 1.65 | 49.7 | Adjuvant (A) | 2018-09-07 | 2018-10-13 | CYTARABINE + ETOPOSIDE | N | null | 240019224 | PEMBROLIZUMAB |
| 240012615 | 240012709 | 1.55 | 77 | Palliative (P) | 2014-11-07 | 2014-11-07 | GEM-P | null | N | 240019309 | FLUDARABINE |
| 240012616 | 240012709 | 1.7 | null | null | 2014-01-16 | 2014-01-27 | R-CHOEP | 2 | null | 240019309 | DOCETAXEL |
| 240012617 | 240015929 | 1.78 | 85.4 | Curative (C) | null | 2017-07-13 | DHAP - R | N | null | 240019353 | VEDEX |
| 240012618 | 240008818 | null | 69.1 | Curative (C) | 2017-03-20 | 2017-03-20 | Carboplatin + Liposomal Doxorubicin | 02 | N | 240019414 | IVAC |
| 240012619 | 240008819 | null | null | Palliative (P) | 2016-07-06 | 2016-07-06 | AML17 TRIAL | N | N | 240019431 | NHL 2003 |
| 240012620 | 240008821 | 1.65 | 32.4 | Palliative (P) | 2015-06-07 | 2015-06-08 | AML17 TRIAL | N | N | 240019486 | IDELALISIB |
| 240012621 | 240008821 | 1.64 | 89.8 | null | 2018-01-10 | 2018-01-12 | GEM-P | N | N | 240019486 | FBC |
| 240012622 | 240008821 | null | 82.1 | Curative (C) | 2017-05-10 | 2017-06-15 | DTPACE | null | N | 240019486 | CYTARABINE HD + METHOTREXATE HD |
| 240012623 | 240008821 | 1.62 | 68.4 | Neo-adjuvant (N) | 2017-06-09 | 2017-07-07 | Cisplatin + Paclitaxel | 2 | N | 240019486 | AML19 TRIAL |
| 240012624 | 240008822 | 1.7 | 83 | Disease modification (D) | 2013-02-27 | 2013-06-14 | AML17 TRIAL | Y | N | 240019720 | CYTARABINE HD + METHOTREXATE HD |
| 240012625 | 240008823 | 1.73 | null | Disease modification (D) | 2014-01-09 | 2014-02-06 | DA-EPOCH-R | null | N | 240019744 | VEDEX |
| 240012626 | 240012712 | 0 | 83.5 | Curative (C) | 2017-05-23 | 2017-05-24 | ATG + Busulfan + Fludarabine | N | N | 240019807 | GEMCITABINE + OXALIPLATIN |
| 240012627 | 240008824 | 1.6 | 65 | Palliative (P) | 2014-02-22 | 2014-02-26 | Cisplatin + Paclitaxel | N | N | 240019889 | CYTARABINE + FLUDARABINE |
| 240012628 | 240008825 | null | null | Disease modification (D) | 2013-05-15 | 2013-05-15 | Capecitabine + Oxaliplatin 21day | N | null | 240019900 | TOPOTECAN |
| 240012629 | 240008825 | 1.7 | 73 | Palliative (P) | 2019-10-15 | 2019-10-15 | ESHAP | 02 | N | 240019900 | CISPLATIN + GEMCITABINE |
| 240012630 | 240008827 | 1.61 | null | Palliative (P) | 2018-01-02 | 2018-02-12 | VINCRISTINE | null | N | 240019983 | CAV |
| 240012631 | 240008828 | 1.71 | 87.7 | Palliative (P) | 2018-07-29 | 2018-07-29 | IVE | 02 | N | 240019983 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240012632 | 240008830 | 1.48 | 62.6 | Curative (C) | 2014-09-19 | 2014-10-11 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 240020261 | IVE |
| 240012633 | 240008830 | null | 63.7 | Palliative (P) | 2016-12-03 | 2016-12-29 | ESHAP | N | N | 240020261 | CLOFARABINE + CYTARABINE |
| 240012634 | 240008833 | null | 75.6 | Palliative (P) | null | 2018-02-15 | IGEV | null | N | 240020368 | NHL 2003 |
| 240012635 | 240008833 | 1.64 | 65.9 | Curative (C) | 2015-03-17 | 2015-03-26 | MABCUTE TRIAL | 02 | Y | 240020368 | NHL 2003 |
| 240012636 | 240008836 | 1.66 | 55.9 | Curative (C) | 2018-08-28 | 2018-10-23 | DA-EPOCH-R | Y | N | 240020387 | CYTARABINE INTRATHECAL |
| 240012637 | 240012719 | 1.61 | 71 | Palliative (P) | 2013-07-01 | 2013-07-01 | Cisplatin + Paclitaxel | 2 | N | 240020509 | DOXORUBICIN |
| 240012638 | 240008839 | 1.82 | 86.6 | null | 2018-06-29 | 2018-06-29 | CISPLATIN + GEMCITABINE | N | N | 240020602 | GEMCITABINE + VINORELBINE |
| 240012639 | 240008840 | 1.59 | 65 | Curative (C) | 2019-03-31 | 2019-03-31 | VEDex | Y | N | 240020675 | CISPLATIN + FLUOROURACIL |
| 240012640 | 240008841 | null | 67.8 | Curative (C) | 2018-12-21 | 2018-12-23 | ICE + GCSF | N | N | 240020675 | PMITCEBO-R |
| 240012641 | 240008844 | 1.68 | 53.8 | Curative (C) | null | 2017-10-24 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | Y | 240020689 | IXAZOMIB + LENALIDOMIDE |
| 240012642 | 240008844 | 1.57 | null | null | 2015-11-23 | 2015-11-23 | CAV | N | N | 240020689 | SORAFENIB |
| 240012643 | 240008845 | 1.68 | 76.1 | Palliative (P) | 2015-09-19 | 2015-10-18 | IVAC | null | N | 240020714 | IVAC |
| 240012644 | 240008845 | null | 54 | Curative (C) | 2017-09-28 | 2017-10-10 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | N | 240020714 | CYCLOPHOSPHAMIDE + VINBLASTINE |
| 240012645 | 240008846 | 1.72 | 55.8 | Palliative (P) | 2016-06-06 | 2016-06-07 | Lomustine | 2 | null | 240020798 | CYCLOPHOSPHAMIDE + VINBLASTINE |
| 240012646 | 240008848 | 1.84 | 93 | Palliative (P) | null | 2015-07-31 | AML 18 Pilot Trial | N | N | 240020856 | ALEMTUZUMAB |
| 240012647 | 240008851 | null | 81.1 | Palliative (P) | 2017-04-13 | 2017-04-13 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 2 | null | 240020870 | OSIMERTINIB |
| 240012648 | 240008852 | 1.66 | 63.5 | Not known (9) | 2017-09-30 | 2017-10-04 | CISPLATIN + GEMCITABINE | 02 | N | 240020907 | DHAP - R |
| 240012649 | 240012729 | 1.66 | 51 | Curative (C) | 2017-06-20 | 2017-06-20 | MABCUTE TRIAL | N | N | 240020924 | FLUOROURACIL + MITOMYCIN + RT |
| 240012650 | 240008854 | 1.81 | 64.1 | Curative (C) | 2017-01-05 | 2017-01-16 | AML18 PILOT TRIAL | 2 | N | 240021063 | IVE |
| 240012651 | 240008855 | 1.63 | 47 | Palliative (P) | 2016-10-04 | 2016-10-06 | Mitoxantrone | 02 | N | 240021075 | CYTARABINE HD + METHOTREXATE HD |
| 240012652 | 240008856 | 1.57 | 83.6 | Curative (C) | 2016-01-01 | 2016-02-26 | ESHAP R | N | N | 240021133 | VINBLASTINE |
| 240012653 | 240008856 | 1.54 | null | Curative (C) | 2016-03-16 | 2016-03-30 | VAC | N | null | 240021133 | CISPLATIN + PACLITAXEL |
| 240012654 | 240008860 | 1.84 | 89.4 | Curative (C) | 2013-03-27 | 2013-04-15 | ESHAP | N | N | 240021189 | GEMCITABINE + OXALIPLATIN |
| 240012655 | 240008861 | 1.8 | 90.8 | Disease modification (D) | 2014-05-09 | 2014-05-11 | Cytarabine HD + Rituximab | N | N | 240021189 | ESHAP |
| 240012656 | 240008864 | 1.59 | 45.8 | Disease modification (D) | 2017-04-21 | 2017-05-03 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 02 | N | 240021267 | CISPLATIN + FLUOROURACIL |
| 240012657 | 240008865 | null | 55.1 | null | 2016-01-07 | 2016-01-22 | R-CHOEP | null | N | 240021267 | CYTARABINE + ETOPOSIDE + MELPHALAN + THIOTEPA |
| 240012658 | 240014550 | 1.6 | null | null | 2014-03-21 | 2014-04-04 | MELPHALAN | N | N | 240021369 | IRINOTECAN + MDG |
| 240012659 | 240008866 | 1.68 | 93 | Curative (C) | 2018-08-25 | 2018-08-30 | ESHAP R | 02 | N | 240021369 | IVAC |
| 240012660 | 240008867 | 1.64 | 61.3 | Palliative (P) | 2016-03-11 | 2016-03-11 | Ofatumumab Loading | 02 | N | 240021702 | PEMBROLIZUMAB |